Results of treatment in hepatic allograft rejection depend on the immunohistologic pattern of the portal T lymphocyte infiltrate.
Perkins
J D
JD
Department of Surgery, Mayo Clinic, Rochester, MN 55905.
Rakela
J
J
Sterioff
S
S
Banks
P M
PM
Wiesner
R H
RH
Krom
R A
RA
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001706:Biopsy; D006084:Graft Rejection; D006801:Humans; D008107:Liver Diseases / Q000175:diagnosis / Q000276:immunology*; D016031:Liver Transplantation; D008775:Methylprednisolone / Q000627:therapeutic use; D011168:Portal System; D013601:T-Lymphocytes / Q000145:classification / Q000276:immunology*
D000911:Antibodies, Monoclonal; D008775:Methylprednisolone